Dr. Coyle discusses the potential role of biotin (vitamin H) in multiple sclerosis, and she and Drs. Lublin, Markowitz, and Riley conclude the program with their final thoughts about what is most valuable—moving forward—in the treatment and management of patients with multiple sclerosis.
Drs. Lublin, Coyle, Markowitz, and Riley, highlight treatment options in the pipeline for multiple sclerosis, remark on the latest data revealed in clinical trials, and share their expectations for future use.
There is still much more to be learned about the effects of depression and cognitive impairment in patients with multiple sclerosis but there are steps being taken to address these issues and help better inform patients of the impact both can play in their lives.
Patients diagnosed with multiple sclerosis may develop depression as a result of the diagnosis but there is also research being done to show that depression can be part of the disease rather than as a result of it.